Is the HIV fight behind or ahead of us? On this AIDS World Day, we will have a panel with key players in the space. These doctors are working on clinical trials to develop drugs to prevent and treat HIV, they work on policies to help bring the interventions where they are needed, and they are also on the ground caring for the individuals needing the care.

Join us to hear how they feel about where we are with the fight.

About the Speakers

Moupali Das, M.D., M.P.H., is vice president of Clinical Development, HIV Prevention and Virology Pediatrics, at Gilead Sciences. She is an infectious diseases/HIV-trained physician with background in academic medicine and public health. As head of HIV Prevention, she leads high-performing cross-functional teams accountable for the overall development strategy and the conception, design and execution of HIV prevention clinical trials from Phase 1 through Phase 4. She is dedicated to ensuring efficient development and regulatory approvals to support rapid access to innovative products to help end the HIV epidemic. She oversees the pediatrics team, which is deeply committed to ensuring the development of pediatric formulations for Gilead’s virology medications.

Demetre C. Daskalakis, M.D., M.P.H., is an infectious disease physician and public health leader recognized for his expertise in infectious diseases and emergency response, with leadership experience at the New York City Department of Health and Mental Hygiene, the CDC, and in the White House National Mpox Response.

Monica Gandhi M.D., M.P.H., is a professor of medicine and associate chief in the Division of HIV, Infectious Diseases, and Global Medicine at the University of California, San Francisco (UCSF). She is also the director of the UCSF Center for AIDS Research (CFAR) and the medical director of the HIV Clinic ("Ward 86") at San Francisco General Hospital. She serves as the associate program director of the ID fellowship at UCSF. Her research focuses on HIV treatment and prevention optimization, HIV and women, adherence measurement in HIV and TB, adherence interventions, and on optimizing the use of long-acting antiretroviral therapy (ART).

Dr. Nas Mohamed is a physician and LGBTQ+ rights advocate whose work bridges medicine, activism and global human rights. He is the founder of Osra Medical, a San Francisco clinic specializing in inclusive, culturally competent care, and the president of the Alwan Foundation, a nonprofit amplifying LGBTQ+ voices from the Gulf region. Through partnerships with Gilead Sciences and ViiV Healthcare, Dr. Mohamed advances HIV prevention education and access. His clinic was among the first in San Francisco to offer both Apretude and Yeztugo, the long-acting injectables for PrEP. Internationally recognized as the first openly gay Qatari, Dr. Mohamed launched the “Love Is Not a Crime” campaign during the FIFA World Cup, advocating for LGBTQ+ rights in regions where same-sex relationships remain criminalized. He also served on the Board of Directors of San Francisco Pride for two years after being selected as the 2023 Grand Marshal by the public vote.